Allen Zhou
Associate Director, Value & Evidence
Expertise:
Allen Zhou is an Associate Director at EVERSANA who specializes in economic modelling.
Since joining EVERSANA in 2018, Allen has developed and led several cost-effectiveness and budget impact modelling projects, has developed a multi-day cost-effectiveness programming course, and mentors other team members on economic modelling. He has contributed to several Canadian, U.S., and Global projects across a wide range of therapeutic areas, including multiple myeloma, lung cancer, breast cancer, neurology, and rare disease.
Allen holds a Bachelor of Applied Science in Nanotechnology Engineering from the University of Waterloo.
Articles by Allen Zhou
Demonstrating the Clinical and Economic Value of Efgartigimod for AChR‑Positive gMG in Canada
Generalized myasthenia gravis (gMG) is a rare autoimmune neuromuscular disease that leads to fluctuating muscle weakness and fatigue, often disrupting daily life. Even with standard therapies, many patients continue to experience persistent symptoms or medication‑related side effects. Chronic immunoglobulin therapy is often used, but it comes with its own challenges, including limited clinical evidence and […]